North America Cytotoxic Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Publisher Name :
Date: 03-Oct-2017
No. of pages: 116

Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably.

Scope of the Report:

This report focuses on the Cytotoxic Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

  • Roche

  • Eli Lilly

  • Celgene

  • Sanofi

  • eisai

  • Sumitomo Dainippon Pharma

  • Merck

  • Seattle Genetics

  • Takeda

  • Haosoh Pharma

  • Novartis

  • AstraZeneca

  • Jazz Pharma

  • Spectrum Pharma

Market Segment by Countries, covering

  • United States

  • Canada

  • Mexico

Market Segment by Type, covers

  • Injection

  • Solid Oral Dose Forms

  • Others

Market Segment by Applications, can be divided into

  • Breast Cancer

  • Blood Cancer

  • Prostate Cancer

  • Respiratory/Lung Cancer

  • Other

There are 15 Chapters to deeply display the North America Cytotoxic Drug market.

Chapter 1, to describe Cytotoxic Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Cytotoxic Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Cytotoxic Drug, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Cytotoxic Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Cytotoxic Drug Research Findings and Conclusion, Appendix, methodology and data source

North America Cytotoxic Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Cytotoxic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Solid Oral Dose Forms
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Respiratory/Lung Cancer
1.3.5 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cytotoxic Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Eli Lilly
2.2.1 Profile
2.2.2 Cytotoxic Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Eli Lilly Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Eli Lilly News
2.3 Celgene
2.3.1 Profile
2.3.2 Cytotoxic Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Sanofi
2.4.1 Profile
2.4.2 Cytotoxic Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofi Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Sanofi News
2.5 eisai
2.5.1 Profile
2.5.2 Cytotoxic Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 eisai Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 eisai News
2.6 Sumitomo Dainippon Pharma
2.6.1 Profile
2.6.2 Cytotoxic Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Sumitomo Dainippon Pharma News
2.7 Merck
2.7.1 Profile
2.7.2 Cytotoxic Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Merck Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Merck News
2.8 Seattle Genetics
2.8.1 Profile
2.8.2 Cytotoxic Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Seattle Genetics Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Seattle Genetics News
2.9 Takeda
2.9.1 Profile
2.9.2 Cytotoxic Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Takeda Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Takeda News
2.10 Haosoh Pharma
2.10.1 Profile
2.10.2 Cytotoxic Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Haosoh Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Haosoh Pharma News
2.11 Novartis
2.11.1 Profile
2.11.2 Cytotoxic Drug Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Novartis Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Novartis News
2.12 AstraZeneca
2.12.1 Profile
2.12.2 Cytotoxic Drug Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 AstraZeneca Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 AstraZeneca News
2.13 Jazz Pharma
2.13.1 Profile
2.13.2 Cytotoxic Drug Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Jazz Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Jazz Pharma News
2.14 Spectrum Pharma
2.14.1 Profile
2.14.2 Cytotoxic Drug Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Spectrum Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Spectrum Pharma News

3 North America Cytotoxic Drug Market Competition, by Manufacturer
3.1 North America Cytotoxic Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Cytotoxic Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Cytotoxic Drug Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Cytotoxic Drug Manufacturer Market Share
3.4.2 Top 5 Cytotoxic Drug Manufacturer Market Share
3.5 Market Competition Trend

4 North America Cytotoxic Drug Market Analysis by Countries
4.1 North America Cytotoxic Drug Sales Market Share by Countries
4.2 North America Cytotoxic Drug Sales by Countries (2012-2017)
4.3 North America Cytotoxic Drug Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Cytotoxic Drug by Type
5.1 North America Cytotoxic Drug Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Cytotoxic Drug Sales and Market Share by Type (2012-2017)
5.1.2 North America Cytotoxic Drug Revenue and Market Share by Type (2012-2017)
5.2 Injection Sales Growth and Price
5.2.1 North America Injection Sales Growth (2012-2017)
5.2.2 North America Injection Price (2012-2017)
5.3 Solid Oral Dose Forms Sales Growth and Price
5.3.1 North America Solid Oral Dose Forms Sales Growth (2012-2017)
5.3.2 North America Solid Oral Dose Forms Price (2012-2017)
5.4 Others Sales Growth and Price
5.4.1 North America Others Sales Growth (2012-2017)
5.4.2 North America Others Price (2012-2017)

6 North America Market Segmentation Cytotoxic Drug by Application
6.1 North America Cytotoxic Drug Sales Market Share by Application (2012-2017)
6.2 Breast Cancer Sales Growth (2012-2017)
6.3 Blood Cancer Sales Growth (2012-2017)
6.4 Prostate Cancer Sales Growth (2012-2017)
6.5 Respiratory/Lung Cancer Sales Growth (2012-2017)
6.6 Other Sales Growth (2012-2017)

7 United States Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Cytotoxic Drug Sales and Market Share by Type
7.3 United States Cytotoxic Drug Sales by Application (2012-2017)
7.4 United States Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Cytotoxic Drug Sales and Market Share by Manufacturer
7.4.2 United States Cytotoxic Drug Revenue and Market Share by Manufacturer
7.5 United States Cytotoxic Drug Export and Import (2012-2017)

8 Canada Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Cytotoxic Drug Sales and Market Share by Type
8.3 Canada Cytotoxic Drug Sales by Application (2012-2017)
8.4 Canada Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Cytotoxic Drug Sales and Market Share by Manufacturer
8.4.2 Canada Cytotoxic Drug Revenue and Market Share by Manufacturer
8.5 Canada Cytotoxic Drug Export and Import (2012-2017)

9 Mexico Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Cytotoxic Drug Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Cytotoxic Drug Sales and Market Share by Type
9.3 Mexico Cytotoxic Drug Sales by Application (2012-2017)
9.4 Mexico Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Cytotoxic Drug Sales and Market Share by Manufacturer
9.4.2 Mexico Cytotoxic Drug Revenue and Market Share by Manufacturer
9.5 Mexico Cytotoxic Drug Export and Import (2012-2017)

10 Cytotoxic Drug Market Forecast (2017-2022)
10.1 North America Cytotoxic Drug Sales, Revenue and Growth Rate (2017-2022)
10.2 Cytotoxic Drug Market Forecast by Countries (2017-2022)
10.2.1 United States Cytotoxic Drug Forecast (2017-2022)
10.2.2 Canada Cytotoxic Drug Forecast (2017-2022)
10.2.3 Mexico Cytotoxic Drug Forecast (2017-2022)
10.3 Cytotoxic Drug Market Forecast by Type (2017-2022)
10.4 Cytotoxic Drug Market Forecast by Application (2017-2022)

11 Cytotoxic Drug Manufacturing Cost Analysis
11.1 Cytotoxic Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cytotoxic Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cytotoxic Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cytotoxic Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Cytotoxic Drug Picture
Table Product Specifications of Cytotoxic Drug
Figure North America Sales Market Share of Cytotoxic Drug by Types in 2016
Table Types of Cytotoxic Drug
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Solid Oral Dose Forms Picture
Table Major Manufacturers of Solid Oral Dose Forms
Figure Others Picture
Table Major Manufacturers of Others
Table North America Cytotoxic Drug Sales Market Share by Applications in 2016
Table Applications of Cytotoxic Drug
Figure Breast Cancer Picture
Figure Blood Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Picture
Figure United States Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Cytotoxic Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cytotoxic Drug Type and Applications
Table Roche Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cytotoxic Drug Type and Applications
Table Eli Lilly Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cytotoxic Drug Type and Applications
Table Celgene Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cytotoxic Drug Type and Applications
Table Sanofi Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table eisai Basic Information, Manufacturing Base and Competitors
Table eisai Cytotoxic Drug Type and Applications
Table eisai Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table Sumitomo Dainippon Pharma Cytotoxic Drug Type and Applications
Table Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cytotoxic Drug Type and Applications
Table Merck Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table Seattle Genetics Cytotoxic Drug Type and Applications
Table Seattle Genetics Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cytotoxic Drug Type and Applications
Table Takeda Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haosoh Pharma Basic Information, Manufacturing Base and Competitors
Table Haosoh Pharma Cytotoxic Drug Type and Applications
Table Haosoh Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cytotoxic Drug Type and Applications
Table Novartis Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cytotoxic Drug Type and Applications
Table AstraZeneca Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jazz Pharma Basic Information, Manufacturing Base and Competitors
Table Jazz Pharma Cytotoxic Drug Type and Applications
Table Jazz Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Spectrum Pharma Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharma Cytotoxic Drug Type and Applications
Table Spectrum Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Cytotoxic Drug Sales by Manufacturer (2016-2017)
Figure North America Cytotoxic Drug Sales Market Share by Manufacturer in 2016
Figure North America Cytotoxic Drug Sales Market Share by Manufacturer in 2017
Table North America Cytotoxic Drug Revenue by Manufacturer (2016-2017)
Figure North America Cytotoxic Drug Revenue Market Share by Manufacturer in 2016
Figure North America Cytotoxic Drug Revenue Market Share by Manufacturer in 2017
Table North America Cytotoxic Drug Price by Manufacturers (2016-2017)
Figure Top 3 Cytotoxic Drug Manufacturer Market Share in 2016
Figure Top 3 Cytotoxic Drug Manufacturer Market Share in 2017
Figure Top 5 Cytotoxic Drug Manufacturer Market Share in 2016
Figure Top 5 Cytotoxic Drug Manufacturer Market Share in 2017
Figure North America Cytotoxic Drug Sales and Growth (2012-2017)
Table North America Cytotoxic Drug Sales by Countries (2012-2017)
Table North America Cytotoxic Drug Sales Market Share by Countries (2012-2017)
Figure North America 2012 Cytotoxic Drug Sales Market Share by Countries
Figure North America 2016 Cytotoxic Drug Sales Market Share by Countries
Figure North America Cytotoxic Drug Revenue and Growth (2012-2017)
Table North America Cytotoxic Drug Revenue by Countries (2012-2017)
Table North America Cytotoxic Drug Revenue Market Share by Countries (2012-2017)
Table North America 2012 Cytotoxic Drug Revenue Market Share by Countries
Table North America 2016 Cytotoxic Drug Revenue Market Share by Countries
Table North America Cytotoxic Drug Sales by Type (2012-2017)
Table North America Cytotoxic Drug Sales Share by Type (2012-2017)
Table North America Cytotoxic Drug Revenue by Type (2012-2017)
Table North America Cytotoxic Drug Revenue Share by Type (2012-2017)
Figure North America Injection Sales Growth (2012-2017)
Figure North America Injection Price (2012-2017)
Figure North America Solid Oral Dose Forms Sales Growth (2012-2017)
Figure North America Solid Oral Dose Forms Price (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure North America Others Price (2012-2017)
Table North America Cytotoxic Drug Sales by Application (2012-2017)
Table North America Cytotoxic Drug Sales Share by Application (2012-2017)
Figure North America Breast Cancer Sales Growth (2012-2017)
Figure North America Blood Cancer Sales Growth (2012-2017)
Figure North America Prostate Cancer Sales Growth (2012-2017)
Figure North America Respiratory/Lung Cancer Sales Growth (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure United States Cytotoxic Drug Revenue and Growth (2012-2017)
Figure United States Cytotoxic Drug Sales and Growth (2012-2017)
Table United States Cytotoxic Drug Sales by Type (2012-2017)
Table United States Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table United States Cytotoxic Drug Sales by Application (2012-2017)
Table United States Cytotoxic Drug Sales Market Share by Application (2012-2017)
Table United States Cytotoxic Drug Sales by Manufacturer (2016-2017)
Figure United States Cytotoxic Drug Sales Market Share by Manufacturer in 2016
Figure United States Cytotoxic Drug Sales Market Share by Manufacturer in 2017
Table United States Cytotoxic Drug Revenue by Manufacturer (2016-2017)
Figure United States Cytotoxic Drug Revenue Market Share by Manufacturer in 2016
Figure United States Cytotoxic Drug Revenue Market Share by Manufacturer in 2017
Table United States Cytotoxic Drug Export and Import (2012-2017)
Figure Canada Cytotoxic Drug Revenue and Growth (2012-2017)
Figure Canada Cytotoxic Drug Sales and Growth (2012-2017)
Table Canada Cytotoxic Drug Sales by Type (2012-2017)
Table Canada Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table Canada Cytotoxic Drug Sales by Application (2012-2017)
Table Canada Cytotoxic Drug Sales Market Share by Application (2012-2017)
Table Canada Cytotoxic Drug Sales by Manufacturer (2016-2017)
Figure Canada Cytotoxic Drug Sales Market Share by Manufacturer in 2016
Figure Canada Cytotoxic Drug Sales Market Share by Manufacturer in 2017
Table Canada Cytotoxic Drug Revenue by Manufacturer (2016-2017)
Figure Canada Cytotoxic Drug Revenue Market Share by Manufacturer in 2016
Figure Canada Cytotoxic Drug Revenue Market Share by Manufacturer in 2017
Table Canada Cytotoxic Drug Export and Import (2012-2017)
Figure Mexico Cytotoxic Drug Revenue and Growth (2012-2017)
Figure Mexico Cytotoxic Drug Sales and Growth (2012-2017)
Table Mexico Cytotoxic Drug Sales by Type (2012-2017)
Table Mexico Cytotoxic Drug Sales Market Share by Type (2012-2017)
Table Mexico Cytotoxic Drug Sales by Application (2012-2017)
Table Mexico Cytotoxic Drug Sales Market Share by Application (2012-2017)
Table Mexico Cytotoxic Drug Sales by Manufacturer (2016-2017)
Figure Mexico Cytotoxic Drug Sales Market Share by Manufacturer in 2016
Figure Mexico Cytotoxic Drug Sales Market Share by Manufacturer in 2017
Table Mexico Cytotoxic Drug Revenue by Manufacturer (2016-2017)
Figure Mexico Cytotoxic Drug Revenue Market Share by Manufacturer in 2016
Figure Mexico Cytotoxic Drug Revenue Market Share by Manufacturer in 2017
Table Mexico Cytotoxic Drug Export and Import (2012-2017)
Figure North America Cytotoxic Drug Sales, Revenue and Growth Rate (2017-2022)
Table North America Cytotoxic Drug Sales Forecast by Countries (2017-2022)
Table North America Cytotoxic Drug Market Share Forecast by Countries (2017-2022)
Figure United States Cytotoxic Drug Sales Forecast (2017-2022)
Figure Canada Cytotoxic Drug Sales Forecast (2017-2022)
Figure Mexico Cytotoxic Drug Sales Forecast (2017-2022)
Table North America Cytotoxic Drug Sales Forecast by Type (2017-2022)
Table North America Cytotoxic Drug Market Share Forecast by Type (2017-2022)
Table North America Cytotoxic Drug Sales Forecast by Application (2017-2022)
Table North America Cytotoxic Drug Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cytotoxic Drug
Figure Manufacturing Process Analysis of Cytotoxic Drug
Figure Cytotoxic Drug Industrial Chain Analysis
Table Raw Materials Sources of Cytotoxic Drug Major Manufacturers in 2016
Table Major Buyers of Cytotoxic Drug
Table Distributors/Traders/ Dealers List
  • Global and United States Oncology Drugs Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 122
    Summary Market Segment as follows: By Type - Oral Therapy - Injectable Therapy By Application - Targeted Therapy - Chemotherapy - Hormonal Therapy - Biologic Therapy By Company - Novartis A.G - Laboratrio Cristlia - Medley Genomics - F. Hoffmann-La Roche Ltd - Icon Plc. - Sanofi S.A. - Laboratoires Pierre Fabre - Eurofarma Laboratrios S.A. - Ach Laboratrios Farmacu......
  • Global and United States Rhabdomyosarcoma Drug Market Research by Company, Type & Application 2013-2025
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 152
    Summary Market Segment as follows: By Type ARI-4175 Celyvir Crizotinib Enoblituzumab AT-69 Axitinib Others By Application Research Center Hospital Clinic Others By Company Bellicum Pharmaceuticals Inc Boehringer Ingelheim GmbH Bristol-Myers Squibb Co Celgene Corp Eisai Co Ltd Epizyme Inc Exelixi......
  • Global and United States Hydroxycarbamide Market Research by Company, Type & Application 2013-2025
    Published: 08-Jul-2018        Price: US 2000 Onwards        Pages: 119
    Summary Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Market Segment as follows: By Type - Capsule - Tablet By Application - Sickle Cell Disease - Cancer - Others By Company - Taj Pharma - Bristol......
  • 2018-2023 Global Lentinan Consumption Market Report
    Published: 05-Jul-2018        Price: US 4660 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Lentinan market for 2018-2023. Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side ef......
  • 2018 Top 5 Lentinan Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 05-Jul-2018        Price: US 4960 Onwards        Pages: 127
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan's efficacy, its market size has been limite......
  • 2013-2023 Global Myelodysplastic Syndrome Drug Industry Report
    Published: 05-Jul-2018        Price: US 4000 Onwards        Pages: 141
    The global market size of Myelodysplastic Syndrome Drug is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This repor......
  • 2013-2023 Global Neuroendocrine Tumors Drug Industry Report
    Published: 05-Jul-2018        Price: US 4000 Onwards        Pages: 145
    The global market size of Neuroendocrine Tumors Drug is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report c......
  • 2013-2023 Global Nucleic Acid Therapies in Oncology Drug Industry Report
    Published: 05-Jul-2018        Price: US 4000 Onwards        Pages: 149
    The global market size of Nucleic Acid Therapies in Oncology Drug is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. ......
  • 2018 Top 5 Cytotoxic Drug Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 05-Jul-2018        Price: US 4960 Onwards        Pages: 140
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. The classification ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs